May 7, 2019
Sanofi’s interleukin-4 receptor alpha antagonist Dupixent (dupilumab) was filed in Japan on April 25 for an additional indication of chronic sinusitis with nasal polyps in adults. Dupixent is already available in Japan for the treatment of atopic dermatitis and asthma...read more